Human T-cell lymphotropic virus type 1 (HTLV-1) is associated with a number of disorders, the most common being adult T-cell leukemia and HTLV-1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP). HAM/TSP is a chronic neurodegenerative disorder whose symptoms are primarily localized to functions associated with the lower spinal cord, including spastic paraplegia of the lower extremities, loss of bladder control, and sexual dysfunction (17, 34) . Pathology is mainly limited to the lower and middle thoracic cords, where marked degeneration of the corticospinal tracts and demyelination are evident, accompanied by perivascular mononuclear infiltrates consisting primarily of CD4 ϩ T lymphocytes in early lesions, followed by the appearance of CD8 ϩ T lymphocytes in older lesions (17, 30) . Another characteristic of patients with HAM/TSP is the observation of highly activated circulating cytotoxic T lymphocytes (CTLs) in both the blood and the cerebrospinal fluid (9, 18) . Remarkably, the vast majority of this response is specific for the product of the HTLV-1 pX region, the transactivating protein referred to as Tax 1 (9, 19, 21) .
These observations have led to a hypothesis that the demyelination and neuronal degeneration observed in HAM/TSP patients result from an immunopathological mechanism, in which HTLV-1 Tax 1 -specific CTLs recognize and destroy infected resident cells in the central nervous system (CNS) (23, 30) . However, a number of observations are not consistent with this hypothesis. First, although several reports have described the detection of HTLV-1 DNA in the CNS (15, 16, 24, 25, 37) , it is unclear if CNS resident cells are actually infected, as opposed to cells in the infiltrate. One study identified some HTLV-1-infected cells as astrocytes (25) , and another was unable to detect proviral DNA in either neuronal or glial cells in the spinal cord of a HAM/TSP patient (15) . Second, high levels of HTLV-1 Tax 1 -specific CTLs have been observed not only in HAM/TSP patients but also in symptom-free HTLV-1 carriers (9) . In light of these findings, it has recently been suggested that the cellular infiltrates observed around spinal cord lesions in HAM/TSP are not effectors in an immunopathological response (1, 8) . Rather, it is the efficiency with which those CTLs can limit viral spread that is the critical factor determining the course of infection with HTLV-1. It was proposed that tissue damage results from a bystander effect caused by the release of cytokines from these highly activated T cells that infiltrate the CNS.
The potent Tax 1 -specific immunity in HTLV-1-infected individuals may reflect the possibilities either that Tax 1 is unusually immunogenic or that it is present in significant amounts in the host. HTLV-1 Tax 1 is a 40-kDa phosphoprotein whose primary function is the transactivation of viral transcription, but it also has the ability to influence the expression of a number of cellular genes (14) . The influence of Tax 1 on cellular gene expression can be observed not only in HTLV-1-infected cells or transfectants expressing the Tax 1 gene, but also in cells treated with soluble Tax 1 , conferring upon it the properties of an extracellular cytokine (2, (26) (27) (28) (29) . Furthermore, it has been observed that cells infected with HTLV-1 actively secrete functional Tax 1 (26, 28) . Soluble Tax 1 treatment induces the nuclear accumulation of NF-B (2, 26) , as well as the expression of immunoglobulin light chain (2, 27), interleukin-2 receptor ␣ (29), tumor necrosis factor alpha (TNF-␣) (11), TNF-␤ (2), and interleukin-6 (11).
In considering a role for Tax 1 in the demyelination and axonal degeneration observed in HAM/TSP, TNF-␣ is of particular interest, since this cytokine is toxic for oligodendrocytes, the source of myelin (36) . Two recent observations are relevant in this regard. First, in a rat model of HAM/TSP, it was observed that Tax gene expression was limited to the diseased spinal cord and correlated with expression of TNF-␣ (39). Second, it has been demonstrated that treatment of primary human microglia with soluble Tax 1 can induce TNF-␣ (11). This study is designed to investigate whether TNF-␣ gene expression in neuronal cells themselves could be induced by soluble HTLV-1 Tax 1 , such that it would potentially play a role in the course of HAM/TSP.
MATERIALS AND METHODS
Cells and reagents. The NTera 2/cl.D1 (NT2) cell line was obtained from the American Type Culture Collection (Rockville, Md.) and was maintained in Opti-MEM I medium (Life Technologies, Gaithersburg, Md.) supplemented with 5% fetal bovine serum (Life Technologies), 2 mM glutamine, and penicillinstreptomycin (NT2 culture medium). NT2-N cells were generated from the parent NT2 cells as described previously (32) . Briefly, 4.5 ϫ 10 6 NT2 cells were seeded in 175-cm 2 tissue culture flasks (Nunc, Naperville, Ill.) in 50-ml NT2 culture medium containing 10 M trans-retinoic acid (Sigma, St. Louis, Mo.), the culture medium being changed twice per week. After 3 to 4 weeks of treatment with retinoic acid, the cells were removed with trypsin, replated at a sixfold-lower density in NT2 culture medium without retinoic acid, and cultured for an additional 2 days. The loosely adherent cells were then recovered in the culture medium by striking the flasks sharply. These cells were replated on eight-chamber glass culture slides (Nunc) that had been pretreated with a 1:60 dilution of Matrigel (Collaborative Research, Cambridge, Mass.), a basement membrane extract, according to the manufacturer's protocol. One hundred thousand cells were placed in each well in NT2 culture medium containing 1 M cytosine arabinoside, 10 M fluorodeoxyuridine, and 10 M uridine as mitotic inhibitors. The cells were cultured for 1 week in the presence of these three inhibitors, followed by 2 to 3 weeks of culture with fluorodeoxyuridine and uridine, with the medium changed weekly. This resulted in a Ͼ95% pure population of NT2-N cells (32) , with approximately 10 4 postmitotic cells remaining in each well. Before use in experiments, the cells were cultured for a minimum of 2 days in NT2 medium without mitotic inhibitors and then were used within 4 to 6 weeks thereafter. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by centrifugation through a Ficoll-Hypaque gradient (Pharmacia, Piscataway, N.J.). Lipopolysaccharide (LPS) was obtained from Sigma.
Recombinant HTLV-1 Tax 1 . HTLV-1 Tax 1 protein was expressed in Escherichia coli (13) and purified by differential precipitation as described previously (12) . Mock bacterial extracts were prepared in an identical fashion from E. coli cells not expressing the Tax 1 gene. For treatment of cells, recombinant Tax 1 solution was mixed with an equal volume of a solution containing 2 mM CHAPS {3-[(cholamidopropyl)-dimethyl-ammonio]-1-propanesulfate}, 2 mM EDTA, 2 mM dithiothreitol, and 20 mM ␤-mercaptoethanol (2ϫ Tax 1 buffer) and incubated at 30°C for 30 min. Medium was then added, and the solution was passed through a 0.22 m-pore-diameter Millex GV4 filter (Millipore, Bedford, Mass.). Two hundred microliters of the treated medium was added per well.
Immunofluorescence. NT2-N cells, cultured as described above in eight-chamber glass culture slides, and NT2 cells, cultured overnight in eight-chamber plastic culture slides (Nunc) (5 ϫ 10 4 cells plated per well), were washed once with phosphate-buffered saline (PBS) and dried for 2 h at room temperature. The cells were then fixed for 10 min in acetone on ice (0.5 ml/well), dried at room temperature, and washed with PBS (0.5 ml/well). For indirect immunofluorescence, cells were treated with either SMI 35 (Sternberger Monoclonals, Baltimore, Md.) (monoclonal antibody to neurofilament H, ascites diluted 1,000-fold in PBS with 1% fetal bovine serum) or with Sp2/0 (control ascites diluted 1,000-fold in PBS with 1% fetal bovine serum) for 1 h at room temperature, followed by four washings for 15 min each with PBS. The cells were then treated with 0.1 ml of secondary antibody (fluorescein-labeled goat anti-mouse immunoglobulin G [IgG] [Kirkegaard and Perry Laboratories, Gaithersburg, Md.], diluted 100-fold in PBS with 1% fetal bovine serum) for 1 h at room temperature in the dark, and washed in PBS as described above. For direct immunofluorescence, cells were treated with 50 l of fluorescein-labeled CAM 5.2 (antikeratin; Becton-Dickinson, San Jose, Calif.) or fluorescein-labeled mouse IgG1 (Becton Dickinson) for 1 h at room temperature in the dark and washed with PBS. Cells were mounted in Vectashield (Vector Laboratories, Burlingame, Calif.) prior to examination for immunofluorescence.
Detection of TNF-␣. Culture supernatants (200 l) were harvested and diluted with 250 l of medium. TNF-␣ was detected with a high-sensitivity enzymelinked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, Minn.) according to the manufacturer's instructions. Each sample was assayed in duplicate.
RT-PCR. For reverse-transcribed PCR (RT-PCR), NT2-N cells were washed once with 0.4 ml of PBS/well, and mRNA was isolated with the QuickPrep Micro mRNA Purification Kit (Pharmacia) according to the manufacturer's protocol. First-strand cDNA was synthesized with a kit (Pharmacia) according to the manufacturer's protocol with random hexamers. The cDNA was then amplified by PCR with primer pairs for human TNF-␣ (5Ј primr, CTTCTGCCTGCTG CACTTTGGA; 3Ј primer, TCCCAAAGTAGACCTGCCCAGA), human nestin (5Ј primer, AGAGGGGAATTCCTGGAG; 3Ј primer, CTGAGGACCAGG ACTCTCTA) (7), human tau (5Ј primer, TCCGCCAGGGACGTGGG; 3Ј primer, GTGCAAATAGTCTACAA) (35) , and human ␤-actin (5Ј primer, TGAC GGGGTCACCCACACTGTGCCCATCTA; 3Ј primer, CTAGAAGCATTTGC GGTGGACGATGGAGGG). The reactions were carried out in a volume of 100 l, and the reaction mixture consisted of 50 pmol of primer; 1ϫ PCR buffer II (Perkin-Elmer, Norwalk, Conn.); 2.5 mM MgCl 2 ; 50 M dATP, dCTP, dGTP, and dUTP (Boehringer Mannheim, Indianapolis, Ind.); 1.25 U of Taq DNA polymerase (Perkin-Elmer); and 1 U of uracil-DNA glycosylase (Boehringer-Mannheim). The samples were initially treated for 10 min at 37°C to remove potentially contaminating amplimers by digestion with the uracil-DNA glycosylase and for 10 min at 95°C to inactivate the enzyme. Amplification of sequences was accomplished by 35 cycles of 15 s at 95°C, 15 s at 46 or 60°C (for nestin and tau primers or for TNF-␣ and ␤-actin primers, respectively), and 30 s at 72°C in a model 9600 thermal cycler (Perkin-Elmer).
Southern hybridization. Ten microliters of the amplification reaction was separated by electrophoresis on a 2% agarose gel. The DNA was then transferred to a nylon membrane (Nytran; Schleicher and Schuell, Keene, N.H.) with the Turboblotter system (Schleicher and Schuell) according to the manufacturer's instructions, by the alkaline transfer protocol. The membranes were hybridized with end-labeled probes end labeled with [␥-
32 P]ATP (6,000 Ci/mmol [New England Nuclear, Boston, Mass.]) as described previously (6) . The following probes were used: nestin, GGAATGCGCTAGTCTCTG; tau, TCCAGGGACC CAATCTTC; TNF-␣, ATCTCTCAGCTCCACGCCATTGGCCAGGAG; and ␤-actin, TCATCACCATTGGCAATGAGCGGT. Hybridization was performed at 60°C for TNF-␣ and ␤-actin probes or at 45°C for nestin and tau probes. After hybridization, the membranes were washed three times briefly with 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at room temperature, followed by two 30-min washes with 2ϫ SSC-1% sodium dodecyl sulfate at the hybridization temperature for each probe. Radioactivity was visualized by exposure of the blots to phosphor screens and analysis on a PhosphorImager (model 445 SI; Molecular Dynamics, Sunnyvale, Calif.).
Immunodepletion of Tax 1 and Western blot analysis. One microgram of E. coli recombinant Tax 1 (100 ng/l) was incubated with 1 g (20 l) of a cocktail of four monoclonal anti-Tax 1 antibodies (TAb 169, 170, 171, and 172 [1:1:1:1 ratio]) or 1 g (10 l) of p53 monoclonal antibody 1 (Oncogene Research Products, Cambridge, Mass.) for immunodepletion as described previously (27) . Adsorbed complexes were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by Western blotting as described previously (27) .
RESULTS
Postmitotic human neuronal cells treated with extracellular HTLV-1 Tax 1 protein produce TNF-␣. It has not been demonstrated that HTLV-1 Tax works as an extracellular cytokine on neuronal cells. As a model system for human neurons, we utilized cells derived from NTera 2/cl.D1 (NT2), a human teratocarcinoma cell line (31, 32) . When treated with retinoic acid, NT2 yields postmitotic cells (NT2-N) expressing a stable, terminally differentiated neuronal phenotype. As shown in Fig.  1a , NT2-N cells exist in clusters, each containing hundreds of cells, from which emanate a series of processes resembling dendrites and axons. This morphology contrasts dramatically with that of the undifferentiated NT2 cells (Fig. 1b) . In addition, NT2-N cells express many neuronal cytoskeletal proteins, secretory markers, and surface markers not expressed by NT2 (31, 32, 41, 42) . For example, NT2-N cells express neurofilament H (Fig. 1c) and tau (Fig. 2) , the latter a marker for CNS neurons (32) . Neither of these markers is expressed by the undifferentiated NT2 cells (Fig. 1d and 2 ). In contrast, NT2 cells express nestin, which is not expressed by NT2-N (Fig. 2) . The morphology of these cells and the pattern of marker expression, including the expression of keratin by NT2 (Fig. 1g) , are identical to those described previously (31, 32) .
In our initial studies, NT2-N cells were cultured overnight in the presence of recombinant HTLV-1 Tax 1 protein at various concentrations. Analysis of RNA derived from these cultures by RT-PCR demonstrated that TNF-␣ transcripts were induced in NT2-N cells treated with Tax 1 in a dose-responsive manner, with transcripts above background detectable down to 0.25 nM Tax 1 (Fig. 3 , lanes 1 to 6 compared to lane 7).
Consistent with these results, assay of the culture supernatants from these cells revealed that whereas supernatants from cells treated with Tax 1 buffer alone did not contain detectable amounts of TNF-␣ (demonstrating that TNF-␣ is not constitutively secreted by NT2-N), TNF-␣ was produced by cells treated with Tax 1 in a dose-responsive manner (Fig. 4) . A minimum of 0.25 nM Tax 1 was required to induce detectable levels of TNF-␣ in the NT2-N cultures.
Specificity of TNF-␣ production by NT2-N for HTLV-1 Tax 1 . The requirement for the Tax 1 protein rather than a copurifying factor in the induction of TNF-␣ in NT2-N was demonstrated in several ways. First, the Tax 1 preparation was subjected to immunoprecipitation with Tax 1 -specific monoclonal antibodies. This treatment completely removed the TNF-␣-inducing activity, assayed both by RT-PCR (Fig. 5 ) and by ELISA (Fig.  6) . In contrast, Tax 1 treated with a control antibody was able to induce TNF-␣ levels in NT2-N similar to those observed with untreated Tax 1 ( Fig. 5 and 6 ). Western blot analysis of the adsorbed immune complexes confirmed that the majority of the Tax 1 was removed by immunoprecipitation with anti-Tax 1 antibodies, whereas a minimal amount of Tax 1 was depleted in samples treated with a control antibody (data not shown).
Second, because there was concern that endotoxin in the recombinant Tax 1 preparation could account for the TNF-␣-inducing activity, NT2-N cells were treated with LPS at concentrations ranging from 10 ng/ml to 1 g/ml. As shown in Fig.  7 , no TNF-␣ was detectable in the cultures of any of the LPS-treated NT2-N cells. In marked contrast, 10-fold fewer PBMCs treated with even the lowest concentration of LPS produced maximal levels of TNF-␣. Third, no TNF-␣ could be detected in culture supernatants from NT2-N treated with a mock bacterial extract that was subjected to procedures identical to those used for purification of the recombinant Tax 1 protein (Fig. 8) . Taken together, these results demonstrate that the induction of TNF-␣ in NT2-N is dependent upon the HTLV-1 Tax 1 protein.
Kinetics of Tax 1 -mediated TNF-␣ induction in NT2-N. The time required for NT2-N to produce TNF-␣ in response to treatment with soluble Tax 1 was examined by treating the cells with 25 nM Tax 1 for various periods. TNF-␣ could be detected in the culture medium at as early as 2 h of treatment (Fig. 9) . Between 2 and 4 h of treatment, a large increase in TNF-␣ was typically observed, accounting for most of the TNF-␣ that 8) . PCR products were analyzed by Southern blotting with probes for TNF-␣ (top) and ␤-actin (bottom). Each lane represents an independent culture. Lane 9 is a control in which RNA was omitted from the cDNA synthesis, after which RT-PCR was performed to monitor for contamination.
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would appear in the culture medium. Maximal levels were observed by 6 h. TNF-␣ synthesis in NT2-N pulsed with Tax 1 . We next asked whether TNF-␣ synthesis by NT2-N required the presence of Tax 1 for the entire culture period. Cells were cultured for 2 days with Tax 1 continually or for only the first 2 h of culture, after which medium without Tax 1 was added. As shown in Fig.  10A , NT2-N cells pulsed with Tax 1 for only 2 h produced as much TNF-␣ as cells cultured with Tax 1 for the entire 2-day culture period. This observation is not likely explained by instability of Tax 1 in the culture, because addition of fresh Tax 1 after the initial 2-h pulsing did not result in a significant increase in TNF-␣ production (Fig. 10A) .
To determine the minimal amount of time that NT2-N could be exposed to Tax Differentiation dependence of Tax 1 -mediated TNF-␣ induction. Since NT2-N is a terminally differentiated product of the NT2 teratocarcinoma cell line, it was of interest to determine if the ability of HTLV-1 Tax 1 to induce TNF-␣ was restricted to the differentiated cells. As shown in Fig. 11 , treatment of NT2 with up to 250 nM HTLV-1 Tax 1 did not result in the production of detectable TNF-␣, in marked contrast to NT2-N. This finding suggests that neuron-specific factors are required to permit the synthesis of TNF-␣ in response to HTLV-1 Tax 1 .
DISCUSSION
Studies of primary human neurons have been hampered by the ability to obtain pure populations of cells readily. NT2-N cells represent a nearly pure (Ͼ95%) population of terminally differentiated, postmitotic cells that bear a striking biochemi- cal, morphological, and functional resemblance to primary human CNS neurons (32, 41, 42) . In addition, these cells have been valuable models for disease (10, 40, 41) and, upon transplantation into the brain, display characteristics expected of fully mature human neurons, including polarity (22) . Taken together, these observations support the use of NT2-N as a useful model with which to examine the influence of HTLV-1 Tax 1 on primary human neurons.
We have demonstrated in NT2-N that a soluble form of the HTLV-1 Tax 1 protein is able to induce TNF-␣ gene transcription and the synthesis of TNF-␣ that can be detected in the culture medium. This effect has been observed with at least five independent purifications of the recombinant Tax 1 protein. TNF-␣ induction is dependent upon the Tax 1 protein itself and not a copurifying factor, based on the findings that anti-Tax 1 antibodies completely inhibited the response and that treatment with a mock protein extract was unable to induce TNF-␣ synthesis. Importantly, we have also ruled out any contribution from contaminating endotoxin, because direct treatment of NT2-N with LPS did not result in any detectable TNF-␣ synthesis. In contrast, PBMCs were exquisitely sensitive to the TNF-␣-inducing effects of LPS. It should be noted in this regard that when considering the significance of TNF-␣ induction in adult human microglia (cells of macrophage origin in the CNS) by recombinant HTLV-1 Tax 1 (11) , the influence of endotoxin can therefore not be ruled out.
The Tax 1 -dependent synthesis of TNF-␣ in NT2-N occurred in a dose-dependent fashion, with a minimum of 0.25 nM Tax 1 required to result in the synthesis of detectable TNF-␣. Interestingly, this is in the concentration range of Tax 1 observed in the culture medium of HTLV-1-infected cells (2) . The induction of TNF-␣ by Tax 1 is relatively rapid in NT2-N, with a significant level of TNF-␣ appearing in the culture medium within 4 h of treatment with Tax 1 and a maximum reached by 6 h. The particular concentration dependence and kinetics of the response to Tax 1 are remarkably similar to those observed for induction of NF-B binding activity by extracellular Tax 1 (2, 26) . Indeed, evidence exists for the involvement of NF-B in the regulation of TNF-␣ gene expression (20) .
A remarkable and critical observation in this system was that NT2-N cells need not be exposed to Tax 1 for prolonged periods to induce TNF-␣. Rather, exposure for only a few minutes is apparently necessary, based on the Tax 1 -pulsing experiments described here in which treatment of NT2-N for as little as 5 min resulted in the synthesis of TNF-␣. It is possible that even shorter exposures may be sufficient, depending upon the concentration of Tax 1 in the microenvironment of the neuron.
Whereas TNF-␣ could be readily induced by extracellular Tax 1 in NT2-N, this was not the case in the parental cell line, NT2. Culturing NT2 in the presence of even 10-fold the concentration of Tax 1 typically used to induce TNF-␣ synthesis in NT2-N was unable to result in detectable levels of TNF-␣ in the culture medium. This observation suggests that differentiation-specific (neuron-specific?) factors may be involved in the ability to produce TNF-␣ in response to soluble Tax 1 . The synthesis of TNF-␣ by neurons is not without precedent and has been observed in vivo. For example, TNF-␣ can be detected in neurons following injury (38) , following systemic administration of LPS (3), or constitutively (4). This constitutive expression, detected at the RNA level, is consistent with our observations of low levels of TNF-␣ transcripts in untreated NT2-N cells. In these contexts, it has been proposed (5) that TNF-␣ functions in a neuroprotective manner and participates in regenerative events following injury, acting as a neuromodulator in the acute-phase response to inflammation and infection.
TNF-␣ in the CNS is associated with pathological events as well. Significantly, TNF-␣ is toxic for the myelin-producing cells of the CNS, the oligodendrocytes (36) . Recently, Probert et al. (33) provided strong support for an in vivo role for TNF-␣ in demyelination. Transgenic mice that expressed a murine TNF-␣ transgene specifically in CNS neurons exhibited spontaneous focal demyelination, accompanied by a prominent lymphocytic infiltrate, astrogliosis, and microgliosis, all of which could be attributed to the expression of the neuronal TNF-␣. These observations are of obvious interest in the context of the pathology observed in HAM/TSP and, considered together with the results presented in this study, suggest that induction of TNF-␣ in neurons by mere transient exposure to extracellular HTLV-1 Tax 1 may play a significant role.
